EE99 R2Loc-VAI

**Semantic type:** Research Activity

**Definition:** Patients randomized with the following course sequence: 1) Group 2 localized disease: Vincristine, dactinomycin, ifosfamide (VAI) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)

**Synonyms:** - EE99:R2Loc-VAI